NCT00494312 - Safety Study of Pioglitazone Compared To Glyburide on Liver Function | Biotech Hunter

Enrollment

2,120

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Diabetes MellitusLiver

Interventions

DRUG

Pioglitazone

Pioglitazone 15 mg or 30 mg titrated to 45 mg, tablets, orally, once daily and glyburide placebo-matching capsules, orally, once daily for up to 156 weeks.

DRUG

Glyburide

Pioglitazone placebo-matching tablets, orally, once daily and glyburide 5 mg or 10 mg titrated to 15 mg, capsules, orally, once daily for up to 156 weeks.